Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

Archives of Pediatric Infectious Diseases - Netherlands
doi 10.5812/pedinfect.22997
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Kowsar Medical Institute

Related search

Drug-Resistant Tuberculosis

Drug and Therapeutics Bulletin
MedicinePharmacology
1995English

Efficacy and Safety of World Health Organization Group 5 Drugs for Multidrug-Resistant Tuberculosis Treatment

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Belarus and Drug-Resistant Tuberculosis

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2019English

Encouraging Drug-Resistant Tuberculosis

BMJ
1953English

Multidrug and Extensively Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2019English

A Clinical Case of Effective Treatment of Extensive Drug Resistance Tuberculosis With New Anti-Tuberculosis Drugs

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2017English

Antibiotic Stewardship for Drug Resistant Tuberculosis

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

The Tuberculosis Network European Trials Group (TBnet) ERS Clinical Research Collaboration: Addressing Drug-Resistant Tuberculosis Through European Cooperation

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2019English

In Vitrosusceptibility Testing and Totally Drug-Resistant Tuberculosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy